Holding(s) in Company

Holdings in Company: e-Therapeutics plc

7 February 2012 e-Therapeutics plc (AIM: ETX) was notified on 6 February that, as of 3 February 2012, RAB Special Situations (Master) Fund Limited no longer has a beneficial holding exceeding 3% of the Company's issued ordinary shares.

Contacts:

e-Therapeutics plc

Daniel Elger

Tel: +44 (0) 7909 915 068

www.etherapeutics.co.uk 

Panmure Gordon (UK) Limited

Andrew Burnett / Fred Walsh

Tel: +44 (0) 20 7459 3600

www.panmure.com